ArticleAmerican journal of cancer research2022

Expression of SLC22A18 regulates oxaliplatin resistance by modulating the ERK pathway in colorectal cancer.

Tae Won Kim et al.PubMed ↗Full text ↗

No numbers read from the abstract.